CompaniesDiversa

Diversa

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

By Status

WITHDRAWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
Today
NCT03296124
Hover over trial bars to see details

Recent Trials

NCT03296124Collaborator
Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32)
N/AWithdrawn
Started: Dec 7, 2017 · Completed: Sep 30, 2020
Funding History (2)
D/A
Mar 12, 2010
Filing
D/A
Mar 11, 2009
Filing
Related Companies
Celunol To Become Verenium----------------------------------------if You Believe Any Of This Information Is Incorrect
merged